WCM
TEVA icon

Weld Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History

Weld Capital Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-60,897
Closed -$588K – 542
2020
Q4 		$588K Sell
60,897
-9,421
-13% -$90.3K 0.23% 151
2020
Q3 		$634K Buy
70,318
+34,061
+94% +$360K 0.25% 138
2020
Q2 		$447K Buy
+36,257
New +$410K 0.18% 204
2019
Q4 		– Sell
-45,988
Closed -$316K – 921
2019
Q3 		$316K Sell
45,988
-38,844
-46% -$298K 0.06% 545
2019
Q2 		$783K Buy
+84,832
New +$1.02M 0.14% 252

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Weld Capital Management's TEVA Position: Q1 2021 in Review

Weld Capital Management sold out of Teva Pharmaceuticals (TEVA) in Q1 2021, closing a stake of 60,897 shares — an estimated $588K sold.

Weld Capital Management first reported a position in TEVA in Q2 2019 and held it in 5 quarters. The position peaked at $783K in Q2 2019. 451 funds tracked by Wall St. Rank hold TEVA as of Q1 2021.

  • Weld Capital Management reported no remaining Teva Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Weld Capital Management sold 60,897 Teva Pharmaceuticals shares in Q1 2021, an estimated $588K.
  • Weld Capital Management first reported a position in Teva Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Weld Capital Management's Teva Pharmaceuticals position peaked at $783K in Q2 2019.
  • 451 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2021.

Based on Weld Capital Management's 13F filing for Q1 2021, filed 17 May 2021.